Mr Matthew Colman > Kirkland & Ellis LLP > Chicago, United States > Lawyer Profile

Kirkland & Ellis LLP
United States
Matthew Colman photo


Matt Colman is a partner in Kirkland’s Technology & IP Transactions Practice Group, focusing on structuring and negotiating complex transactions involving technology, intellectual property, content, and data, including mergers and acquisitions, minority investments, debt financings, joint ventures, strategic alliances, license agreements, development agreements, and services agreements.

Matt also regularly advises clients on the collection, sharing, and monetization of data, cross-border data transfers, the protection of sensitive information, and development of incident response plans. 

Lawyer Rankings

United States > Media, technology and telecoms > Technology transactions

Kirkland & Ellis LLP handles joint ventures, IT outsourcing, licensing agreements and prominent M&A-related technology transactions for clients from the private equity, aviation, pharmaceutical, telecoms and fashion sectors. Recent highlights for the team included advising GlaxoSmithKline on its agreement with Pfizer to combine consumer health businesses into a new joint venture. Key names include patents expert Neil Hirshman; Seth Traxler, who is noted for his experience in handling matters involving technology assets; and Palo Alto-based Vladimir Khodosh, who is very experienced in advising on software licensing mandates. Also recommended are Matthew Colman, Aaron Lorber, Adam Petravicius and New York-based Shellie Weisfield Freedman. Unless stated otherwise, all named attorneys are based in Chicago.

United States > Intellectual property > Patents: licensing

Kirkland & Ellis LLP acts for licensors and licensees alike, thereby offering clients experience in negotiating from both ends of the table. The practice regularly assists with joint development agreements, supply agreements and agreements pertaining to the provision of services and technical assistance. Another area of strength is the development and implementation of patent licensing programs, often by way of corporate transactions, such as joint ventures or divestitures, but also by way of securitisations, synthetic royalties, royalty buy-outs and royalty interests. The arrival of Shellie Weisfield Freedman from Gibson, Dunn & Crutcher LLP in January 2019 bolstered the group’s New York bench. Fellow New Yorker David MacDonald and the Chicago-based Seth TraxlerNeil Hirshman, Matthew Colman and Adam Petravicius are the other key contacts.